Literature DB >> 12829625

Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling.

Joost J F P Luiken1, Susan L M Coort, Jodil Willems, Will A Coumans, Arend Bonen, Ger J van der Vusse, Jan F C Glatz.   

Abstract

Contraction of rat cardiac myocytes induces translocation of fatty acid translocase (FAT)/CD36 and GLUT4 from intracellular stores to the sarcolemma, leading to enhanced rates of long-chain fatty acid (FA) and glucose uptake, respectively. Because intracellular AMP/ATP is elevated in contracting cardiac myocytes, we investigated whether activation of AMP-activated protein kinase (AMP kinase) is involved in contraction-inducible FAT/CD36 translocation. The cell-permeable adenosine analog 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) and the mitochondrial inhibitor oligomycin, similar to 4-Hz electrostimulation, evoked a more than threefold activation of cardiomyocytic AMP kinase. Both AICAR and oligomycin stimulated FA uptake into noncontracting myocytes by 1.4- and 2.0-fold, respectively, but were ineffective in 4 Hz-contracting myocytes. These findings indicate that both agents stimulate FA uptake by a similar mechanism as electrostimulation, involving activation of AMP kinase, as evidenced from phosphorylation of acetyl-CoA carboxylase. Furthermore, the stimulating effects of both AICAR and oligomycin were antagonized by blocking FAT/CD36 with sulfo-N-succinimidylpalmitate, but not by inhibiting phosphatidylinositol 3-kinase with wortmannin, indicating the involvement of FAT/CD36, but excluding a role for insulin signaling. Subcellular fractionation showed that oligomycin was able to mobilize intracellularly stored FAT/CD36 to the sarcolemma. We conclude that AMP kinase regulates cardiac FA use through mobilization of FAT/CD36 from a contraction-inducible intracellular storage compartment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829625     DOI: 10.2337/diabetes.52.7.1627

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  76 in total

Review 1.  AMP-activated protein kinase: the guardian of cardiac energy status.

Authors:  D Grahame Hardie
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 2.  AMP-activated protein kinase: a master switch in glucose and lipid metabolism.

Authors:  D Grahame Hardie
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.

Authors:  Xiangping Fang; Rengasamy Palanivel; Justin Cresser; Kristin Schram; Riya Ganguly; Farah S L Thong; Joseph Tuinei; Aimin Xu; E Dale Abel; Gary Sweeney
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-24       Impact factor: 4.310

4.  Regulation of fatty acid transport: from transcriptional to posttranscriptional effects.

Authors:  Adrian Chabowski; Jan Górski; Arend Bonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-07       Impact factor: 3.000

5.  Tissue-specific and fatty acid transporter-specific changes in heart and soleus muscle over a 1-yr period.

Authors:  Arend Bonen; James G Nickerson; Iman Momken; Adrian Chabowski; Jorge Calles-Escandon; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

6.  Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts.

Authors:  Adrian Chabowski; Iman Momken; Susan L M Coort; Jorge Calles-Escandon; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken; Arend Bonen
Journal:  Mol Cell Biochem       Date:  2006-05-19       Impact factor: 3.396

7.  Insulin and AMPK regulate FA translocase/CD36 plasma membrane recruitment in cardiomyocytes via Rab GAP AS160 and Rab8a Rab GTPase.

Authors:  Dmitri Samovski; Xiong Su; Yingcheng Xu; Nada A Abumrad; Philip D Stahl
Journal:  J Lipid Res       Date:  2012-02-06       Impact factor: 5.922

Review 8.  Cardiac metabolism in heart failure: implications beyond ATP production.

Authors:  Torsten Doenst; Tien Dung Nguyen; E Dale Abel
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

9.  Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle.

Authors:  Graham P Holloway; Jamie Lally; James G Nickerson; Hakam Alkhateeb; Laelie A Snook; George J F Heigenhauser; Jorge Calles-Escandon; Jan F C Glatz; Joost J F P Luiken; Lawrence L Spriet; Arend Bonen
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

10.  Contractions but not AICAR increase FABPpm content in rat muscle sarcolemma.

Authors:  Jacob Jeppesen; Peter Albers; Joost J Luiken; Jan F C Glatz; Bente Kiens
Journal:  Mol Cell Biochem       Date:  2009-01-14       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.